Orgenesis Inc. (NASDAQ: ORGS)
$0.71
+0.0099 ( +1.41% ) 38.6K
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.
Market Data
Open
$0.71
Previous close
$0.70
Volume
38.6K
Market cap
$33.05M
Day range
$0.70 - $0.74
52 week range
$0.25 - $1.31
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 3 | May 06, 2024 |
ars | Annual reports | 1 | May 06, 2024 |
8-k | 8K-related | 13 | Apr 19, 2024 |
10-q/a | Quarterly Reports | 64 | Apr 15, 2024 |
8-k | 8K-related | 13 | Apr 15, 2024 |
10-q/a | Quarterly Reports | 54 | Apr 15, 2024 |
10-q/a | Quarterly Reports | 72 | Apr 15, 2024 |
10-k | Annual reports | 128 | Apr 15, 2024 |
8-k | 8K-related | 14 | Apr 11, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |